최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기생약학회지, v.38 no.2 = no.149, 2007년, pp.197 - 203
강한샘 ((주)이코바이오) , 김광윤 ((주)이코바이오) , 정일 ((주)이코바이오) , 오성덕 ((주)이코바이오) , 김창훈 ((주)이코바이오) , 심봉섭 ((주)이코바이오) , 박근형 (전남대학교 농업생명과학대학 응용생물공학부) , 오석중 ((주)이코바이오)
Benign prostatic hyperplasia (BPH) is one of the common disease in elderly men. Recently old-age population is increased and we are growing more and more interested in clinical importance of BPH. In this study, the effect of PLX, which was the mixture of tomato extract (including 2% of lycopene) and...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Rhoehrborn, C. G., Marks, L., Harkaway, R. (2006) Enlarged prostate: A landmark national survey of its prevalence and impact on US men and their partners. Prostate Cancer Prostatic Dis 9: 30-34
AUA Practice Guidelines Committee. (2003) AUA guideline on management of benign prostatic hyperplasia, Chapter 1: Diagnosis and treatment recommendations. J Urol 170: 530-547
Clark, R. V., Hermann, D. J., Cunningham, G. R., Wilson, T. H., Morrill, B. B., Hobbs, S. (2004) Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5 $\alpha$ -reductase inhibitior. J Clin Endocrinol Metab 89: 2179-2184
Isaacs, J. T. (1984) Antagonistic effect of androgen on prostatic cell death. Prostate 5: 545-557
Nixon, P. (1997) New clinical trial of medical therapy for benign prostatic hyperplasia. Drug Benefit Trends 9: 44-45
Bonkhoff, H., Stein, U., Aumuller, G., Remberger, K. (1996) Differential expression of 5 alpha-reductase isoenzymes in the human prostate and prostatic carcinomas. Prostate 29: 261-267
Lehle, C., Radvanyi, F., Gil Diez de Medina, S. (1999) Differences in steroid 5 alpha-reductase iso-enzymes expression between normal and pathological human prostate tissue. J Steroid Biochem Mol Biol 68: 189-195
Silver, R. I., Wiley, E. L., Davis, D. L., Thigpen, A. E., Russell, D. W., McConnell, J. D. (1994) Expression and regulation of steroid 5 alpha-reductase 2 in prostate disease. J Urol 152: 433-437
Di Silverio, F., Flammia, G. P., Sciarra, A. (1993) Plant extracts in benign prostatic hyperplasia, Minerva Urol Nefrol 45: 143-149
Buck, A. C. (1996) Phytotherapy for the prostate. Br J Urol 78: 325-326
Bales, G. T., Christiano, A. P., Kirsh, E. J., Gerber, G. S. (1999) Phytotherapeutic agents in the treatment of lower urinary track symptoms: a demographic analysis of awareness and use at the University of Chicago. Urology 54: 86-89
Wilt, T. J., MacDonald, R., Ishani, A. (1999) Beta-sisterol for the treatment of benign prostatic hyperplasia: a systematic review. BJU International 83: 976-983
Wilt, T. J., Ishani, A., Stark, G. (1998) Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review. JAMA 280: 1604-1609
Pannala, A. S., Rice-Evans, C., Sampson, J., Sin, S. (1998) Interaction of peroxynitrite with carotenoids and tocopherols within low density lipoprotein. FEBS Letters 423: 297-301
Xing, N., Chen, Y., Mitchell, S. H., Young, C. V. (2001) Quercetin inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells. Carcinogenesis 22: 409-414
Friendman, M. (2002) Tomato glycoalkaloids: role in the plant and in the diet. J Agric Food Chem 50: 5751-5760
Giovannucci, E., Rimm, E. B., Liu, Y., Stampfer, M. J., Willett, W. C. (2002) A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst 94: 391-398
Siler, U., Barella, L., Spitzer, V., Schnorr, J., Lein, M., Goralczyk, R., Wertz, K. (2004) Lycopene and vitamin E interfere with autocrine/paracrine loops in the dunning prostate cancer model. FASEB J 14: 1-23
Jameela, S. R., Misra, A., Jayakrishnan, A. (1994) Cross-linked chitosan microspheres as carriers for prolonged delivery of macromolecular drugs. J Biomater Sci Polym Ed 6: 621-632
Okamoto, Y., Inoue, A., Miyatake, K., Ogihara, K., Shigemasa, Y., Minami, S. (2003) Effects of chitin/shitosan and their oligomers/monomers on migrations of macrophages. Macromol Biosci 3: 587-590
Gerasimenko, D. V., Avdienko, I. D., Bannikova, G. E., Zueva, O. Y., Varlamov, V. P. (2004) Antibacterial effects of water-soluble low-molecular-weight chitosans on different microorganisms. Appl Biochem Microbiol 40: 253-257
Tokoro, A., Tatewaki, N., Suzuki, K., Mikami, T., Suzuki, S., Suzuki, M. (1998) Growth inhibitory effect of hexa-N-acetylchitohexaose and chitohexaos and Meth-A solid tumor. Chem Pharm Bull 36: 784-790
Jeon, T. I., Hwang, S. G., Park, N. G., Jung, Y. R., Shin, S. I., Choi, S. D., Park, D. K. (2003) Antioxidative effect of chitosan on chronic carbon tetrachloride induced hepatic injury in rats. Toxicology 187: 67-73
Di Mascio, P., Kaiser, S., Sies, H. (1989) Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Soc Trans 24: 1023-1027
Kotakanara, E., Kushiro, M., Zhang, H., Sugawara, T., Myashita, K., Nagao, A. (2001) Carotenoids affect proliferation of human prostate cancer cells. J Nutr 131: 3303-3306
Berry, S. J., Coffey, D. S., Strandberg, J. D., Ewing, L. L. (1986) Effect of age, castration and testosterone replacement on the development and restoration of canine benign prostatic hyperplasia. Prostate 9: 295-302
Karr, J. P., Kim, U., Resko, J. A., Schneider, S., Chai, L. S., Murphy, G. P., Sandbery, A. A. (1984) Induction of benign prostatic hypertrophy in baboons. Urology 23: 276-289
Schroeder, F. H. (1983) Current models and their relation to human diseases. In Hinman, F. (ed.), Benign prostatic hypertophy, 215-228. Springer Verlag, New York, USA
Coffey, D. S., Walsh, P. C. (1990) Clinical and experimental studies of benign prostatic hyperplasia. Urol Clin North Am 17: 461-475
Constantinou, C. E. (1996) Influence of hormone treatment on prostate growth and micturition characteristics of the rat. Prostate 26: 30-35
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.